Program Description

The Blood-based Diseases Program Initiative is intended to promote research into health conditions such as the lymphomas, the leukemias, and sickle cell anemia. The lymphomas (Hodgkin's and non-Hodgkin's) are each a group of several closely related cancers. Lymphomas are the most common blood cancer and the 3rd most common cancer of childhood. Non-Hodgkin's lymphoma is the 6th most common form of cancer, but has an overall five-year survival rate of only 59%. Hodgkin's lymphoma is the more rare form of lymphoma and has a significantly better survival rate. Similarly, the leukemias are a family of related diseases. A variety of treatment options exist with differing levels of success and complications. Sickle cell anemia is a serious disease of the red blood cells that currently has no universal cure. Careful health care management has increased affected patients lifespan, however treatment options are limited. Bone marrow transplantation offers a cure to a select few that have properly matched donors.

Each of these diseases has profound affects on society and is in need of much greater attention.

Support for this program has been received from:

• Anonymous Private Donations
• IFSH General Fund

Projects

We are currently seeking additional support for implementation of this program.